We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Plavix Launched in Wake of Federal Investigation, Regulatory Rejection
Generic Plavix Launched in Wake of Federal Investigation, Regulatory Rejection
August 8, 2006
The patent settlement between sanofi-aventis, Bristol-Myers Squibb (BMS) and Apotex designed to prevent the sale of generic Plavix has been abandoned by all parties at the same time it became the focus of a federal antitrust investigation.